Adam Keller Ashton. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Benzhydryl Compounds/therapeutic useCentral Nervous System Stimulants/therapeutic useComorbidityDisorders of Excessive Somnolence/drug therapyDisorders of Excessive Somnolence/epidemiologyDrug Therapy, CombinationDysthymic Disorder/drug therapyDysthymic Disorder/epidemiologyDysthymic Disorder/psychologyFatigue/drug therapyFatigue/epidemiologyFemaleHumansMiddle AgedModafinilMonoamine Oxidase Inhibitors/therapeutic usePhenelzine/therapeutic useTreatment Outcome
Substances： See more » Benzhydryl CompoundsCentral Nervous System StimulantsMonoamine Oxidase InhibitorsPhenelzineModafinil
Year: 2004 PMID： 15337670 DOI： 10.1176/appi.ajp.161.9.1716-a
Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112